Results 241 to 250 of about 134,783 (292)
Non-invasive MRI biomarkers for assessment of neoadjuvant chemotherapy response in osteosarcoma: Current techniques and clinical perspectives. [PDF]
Naghizadeh H +5 more
europepmc +1 more source
The scoping review summarizes the current preclinical and clinical evidence for the use of “cell‐free” therapies in craniofacial (periodontal, bone and soft‐tissue) regeneration. It also aims to highlight key challenges and strategies towards the clinical translation of these therapies.
Siddharth Shanbhag +6 more
wiley +1 more source
Clinical significance of YAP and androgen receptor expression in osteosarcoma: Evidence from a retrospective cohort study. [PDF]
Wang J, Xiang P, Zou C, Wang J.
europepmc +1 more source
Gossypiboma‐associated sarcomas in five cases
Objectives To report clinical presentation, treatment and outcome of dogs and cats diagnosed with gossypiboma‐associated sarcoma. Materials and Methods Referral centres within the United Kingdom, Europe, North America and Australia were contacted to search medical records for dogs and cats with documented gossypiboma‐associated sarcoma and included if ...
G. Thomas +8 more
wiley +1 more source
AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism. [PDF]
Su S, Zeng Y, Chen J, Dong X.
europepmc +1 more source
Clinicopathologic Analysis of Sarcomas in the Oral and Maxillofacial Region: A Systematic Review
ABSTRACT Objective This study aimed to systematically review primary sarcomas in the oral and maxillofacial region, focusing on patient demographics and sarcoma‐specific characteristics, including clinical presentation, histopathology, treatment approaches, outcomes, and survival rates.
Iara Vieira Ferreira +7 more
wiley +1 more source
Formononetin suppresses osteosarcoma by targeting MYO1B and remodeling the tumor immune microenvironment. [PDF]
Liu Y +17 more
europepmc +1 more source

